1. Home
  2. VERA vs ADUS Comparison

VERA vs ADUS Comparison

Compare VERA & ADUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • ADUS
  • Stock Information
  • Founded
  • VERA 2016
  • ADUS 1979
  • Country
  • VERA United States
  • ADUS United States
  • Employees
  • VERA N/A
  • ADUS N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • ADUS Medical/Nursing Services
  • Sector
  • VERA Health Care
  • ADUS Health Care
  • Exchange
  • VERA Nasdaq
  • ADUS Nasdaq
  • Market Cap
  • VERA 2.5B
  • ADUS 2.0B
  • IPO Year
  • VERA 2021
  • ADUS 2009
  • Fundamental
  • Price
  • VERA $42.01
  • ADUS $126.02
  • Analyst Decision
  • VERA Strong Buy
  • ADUS Buy
  • Analyst Count
  • VERA 9
  • ADUS 9
  • Target Price
  • VERA $53.56
  • ADUS $132.00
  • AVG Volume (30 Days)
  • VERA 683.6K
  • ADUS 101.3K
  • Earning Date
  • VERA 11-07-2024
  • ADUS 11-04-2024
  • Dividend Yield
  • VERA N/A
  • ADUS N/A
  • EPS Growth
  • VERA N/A
  • ADUS 26.93
  • EPS
  • VERA N/A
  • ADUS 4.20
  • Revenue
  • VERA N/A
  • ADUS $1,114,740,000.00
  • Revenue This Year
  • VERA N/A
  • ADUS $11.37
  • Revenue Next Year
  • VERA N/A
  • ADUS $14.93
  • P/E Ratio
  • VERA N/A
  • ADUS $30.77
  • Revenue Growth
  • VERA N/A
  • ADUS 11.57
  • 52 Week Low
  • VERA $9.68
  • ADUS $78.35
  • 52 Week High
  • VERA $50.78
  • ADUS $136.12
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • ADUS 49.94
  • Support Level
  • VERA $39.22
  • ADUS $127.01
  • Resistance Level
  • VERA $50.00
  • ADUS $130.60
  • Average True Range (ATR)
  • VERA 2.41
  • ADUS 2.05
  • MACD
  • VERA 0.24
  • ADUS -0.22
  • Stochastic Oscillator
  • VERA 28.53
  • ADUS 44.36

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About ADUS Addus HomeCare Corporation

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Share on Social Networks: